Spyre Therapeutics, Inc.
SYRE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11 | -$37 | -$45 | -$56 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $9 | $9 | $9 |
| Change in WC | $6 | -$9 | -$1 | $11 |
| Other Non-Cash | -$32 | -$10 | -$5 | -$1 |
| Operating Cash Flow | -$37 | -$47 | -$41 | -$37 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$74 | -$35 | -$71 | -$233 |
| Inv. Sales/Matur. | $99 | $107 | $71 | $63 |
| Other Inv. Act. | $0 | $7 | $0 | $0 |
| Investing Cash Flow | $25 | $79 | -$0 | -$171 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $1 | $0 | $225 |
| Stock Repurch. | $0 | $0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5 | $0 | $0 | $1 |
| Financing Cash Flow | -$5 | $1 | $0 | $226 |
| Forex Effect | $0 | $0 | $0 | -$0 |
| Net Chg. in Cash | -$17 | $33 | -$41 | $18 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $82 | $48 | $89 | $72 |
| End Cash | $65 | $82 | $48 | $89 |
| Free Cash Flow | -$37 | -$47 | -$41 | -$37 |